Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Folliculotropic mycosis fungoides is a rare variant of mycosis fungoides (MF), a form of cutaneous T-cell lymphoma, and is characterized by the presence of folliculotropic infiltrates in patch-plaque lesions usually involving the head and neck area.
Biomarker and diagnostic research for folliculotropic mycosis fungoides has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered, 2 recruiting. Interventions under study include other interventions, biologic therapy, drug therapy, and procedural interventions. Pipeline includes 1 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
40 publications have been identified in PubMed for folliculotropic mycosis fungoides. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (10%), and Clinical Trial Publication (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 20 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 1:03 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
50%
Research summaries | 4 | 10% |
Clinical study results | 4 | 10% |
New treatment approaches | 4 | 10% |
Testing and diagnosis research | 3 | 8% |
Other research | 2 | 5% |
Laboratory research | 2 | 5% |
Disease patterns and progression | 1 | 3% |
Paz MC (2026). [PMID: 41610469](https://pubmed.ncbi.nlm.nih.gov/41610469/). *Journal of comparative pathology*. [Case Report / Case Series]
Schukow C (2026). [PMID: 36944007](https://pubmed.ncbi.nlm.nih.gov/36944007/). *Unknown Journal*. [Review / Meta-Analysis]
Giorgio CMR (2026). [PMID: 42190205](https://pubmed.ncbi.nlm.nih.gov/42190205/). *Dermatol Pract Concept*. [Other]
Kim KS (2026). [PMID: 41577077](https://pubmed.ncbi.nlm.nih.gov/41577077/). *The Journal of investigative dermatology*. [Gene Therapy / Novel Therapeutics]
Malinić M (2026). [PMID: 42075487](https://pubmed.ncbi.nlm.nih.gov/42075487/). *Medicina (Kaunas)*. [Review / Meta-Analysis]
Blomen CL (2026). [PMID: 41789498](https://pubmed.ncbi.nlm.nih.gov/41789498/). *Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG*. [Case Report / Case Series]
Vieira Granja B (2026). [PMID: 41749031](https://pubmed.ncbi.nlm.nih.gov/41749031/). *International journal of dermatology*. [Clinical Trial Publication]
Likittanasombat S (2026). [PMID: 41789054](https://pubmed.ncbi.nlm.nih.gov/41789054/). *Case reports in dermatology*. [Case Report / Case Series]
Yazici S (2026). [PMID: 41546654](https://pubmed.ncbi.nlm.nih.gov/41546654/). *International journal of dermatology*. [Review / Meta-Analysis]
Foo CY (2025). [PMID: 41439208](https://pubmed.ncbi.nlm.nih.gov/41439208/). *Case reports in hematology*. [Gene Therapy / Novel Therapeutics]